Treatment of Myelofibrosis: Old and New Strategies

Por Iurlo, Alessandra, Cattaneo, Daniele
Publicado no Clin Med Insights Blood Disord (2017)

Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options

Por Iurlo, Alessandra, Cattaneo, Daniele, Gianelli, Umberto
Publicado no Int J Mol Sci (2019)

New Perspectives on Polycythemia Vera: From Diagnosis to Therapy

Por Iurlo, Alessandra, Cattaneo, Daniele, Bucelli, Cristina, Baldini, Luca
Publicado no Int J Mol Sci (2020)

Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge

Por Iurlo, Alessandra, Cattaneo, Daniele, Bucelli, Cristina, Breccia, Massimo
Publicado no J Clin Med (2021)

Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemothe...

Por Bucelli, Cristina, Cattaneo, Daniele, Ferla, Valeria, Zappa, Manuela, de Benedittis, Caterina, Soverini, Simona, Iurlo, Alessandra
Publicado no Case Rep Hematol (2017)

Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase

Por Breccia, Massimo, Abruzzese, Elisabetta, Iurlo, Alessandra, Gozzini, Antonella, Isidori, Alessandro, Gangemi, Domenica, Pregno, Patrizia, Alimena, Giuliana
Publicado no Haematologica (2016)

Imatinib and ruxolitinib association: first experience in two patients

Por Iurlo, Alessandra, Gianelli, Umberto, Rapezzi, Davide, Cattaneo, Daniele, Fermo, Elisa, Binda, Francesca, Santambrogio, Elisa, Bucelli, Cristina, Cortelezzi, Agostino
Publicado em 2014

Erdheim–Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report

Por Iurlo, Alessandra, Dagna, Lorenzo, Cattaneo, Daniele, Orofino, Nicola, Bianchi, Paola, Cavalli, Giulio, Doglioni, Claudio, Gianelli, Umberto, Cortelezzi, Agostino
Publicado no Medicine (Baltimore) (2016)

The Role of New Technologies in Myeloproliferative Neoplasms

Por Palumbo, Giuseppe A., Stella, Stefania, Pennisi, Maria Stella, Pirosa, Cristina, Fermo, Elisa, Fabris, Sonia, Cattaneo, Daniele, Iurlo, Alessandra
Publicado no Front Oncol (2019)

Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia

Por Annunziata, Mario, Bonifacio, Massimiliano, Breccia, Massimo, Castagnetti, Fausto, Gozzini, Antonella, Iurlo, Alessandra, Pregno, Patrizia, Stagno, Fabio, Specchia, Giorgina
Publicado no Front Oncol (2020)

An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review

Por Orofino, Nicola, Cattaneo, Daniele, Bucelli, Cristina, Pettine, Loredana, Fabris, Sonia, Gianelli, Umberto, Fracchiolla, Nicola Stefano, Cortelezzi, Agostino, Iurlo, Alessandra
Publicado no Leuk Res Rep (2017)

Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response

Por Iurlo, Alessandra, Gianelli, Umberto, Beghini, Alessandro, Spinelli, Orietta, Orofino, Nicola, Lazzaroni, Francesca, Cambiaghi, Stefano, Intermesoli, Tamara, Rambaldi, Alessandro, Cortelezzi, Agostino
Publicado em 2014

HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases

Por Fiori, Stefano, Todisco, Elisabetta, Ramadan, Safaa, Gigli, Federica, Falco, Patrizia, Iurlo, Alessandra, Rampinelli, Cristiano, Croci, Giorgio, Pileri, Stefano A., Tarella, Corrado
Publicado no Biology (Basel) (2021)

Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality

Por Fattizzo, Bruno, Giannotta, Juri Alessandro, Sciumè, Mariarita, Cattaneo, Daniele, Bucelli, Cristina, Fracchiolla, Nicola Stefano, Onida, Francesco, Baldini, Luca, Barcellini, Wilma, Iurlo, Alessandra
Publicado no Leukemia (2020)

Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?

Por Iurlo, Alessandra, Orsi, Emanuela, Cattaneo, Daniele, Resi, Veronica, Bucelli, Cristina, Orofino, Nicola, Sciumè, Mariarita, Elena, Chiara, Grancini, Valeria, Consonni, Dario, Orlandi, Ester Maria, Cortelezzi, Agostino
Publicado no Oncotarget (2015)

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis f...

Por Breccia, Massimo, Olimpieri, Pier Paolo, Olimpieri, Odoardo, Pane, Fabrizio, Iurlo, Alessandra, Foggi, Paolo, Cirilli, Alessia, Colatrella, Antonietta, Cuomo, Marcello, Gozzo, Lucia, Summa, Valentina, Corradini, Paolo, Russo, Pierluigi
Publicado no Cancer Med (2020)

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease...

Por Geyer, Julia T., Margolskee, Elizabeth, Krichevsky, Spencer A., Cattaneo, Daniele, Boiocchi, Leonardo, Ronchi, Paola, Lunghi, Francesca, Scandura, Joseph M., Ponzoni, Maurilio, Hasserjian, Robert P., Gianelli, Umberto, Iurlo, Alessandra, Orazi, Attilio
Publicado no Haematologica (2020)

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey

Por Palandri, Francesca, Piciocchi, Alfonso, De Stefano, Valerio, Breccia, Massimo, Finazzi, Guido, Iurlo, Alessandra, Fazi, Paola, Soddu, Stefano, Martino, Bruno, Siragusa, Sergio, Albano, Francesco, Passamonti, Francesco, Vignetti, Marco, Vannucchi, Alessandro M.
Publicado no Leukemia (2020)

COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

Por Breccia, Massimo, Piciocchi, Alfonso, De Stefano, Valerio, Finazzi, Guido, Iurlo, Alessandra, Fazi, Paola, Soddu, Stefano, Martino, Bruno, Palandri, Francesca, Siragusa, Sergio, Albano, Francesco, Passamonti, Francesco, Vignetti, Marco, Vannucchi, Alessandro M.
Publicado no Leukemia (2020)

Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study

Por Cattaneo, Daniele, Croci, Giorgio Alberto, Bucelli, Cristina, Tabano, Silvia, Cannone, Marta Giulia, Gaudioso, Gabriella, Barbanti, Maria Chiara, Barbullushi, Kordelia, Bianchi, Paola, Fermo, Elisa, Fabris, Sonia, Baldini, Luca, Gianelli, Umberto, Iurlo, Alessandra
Publicado no Front Oncol (2021)